No Data
Form 144 | RxSight(RXST.US) Director Proposes to Sell 922.34K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 14, $RxSight(RXST.US)$ Director Julie Andrews intends to sell 15,625 shares of its common stock on Jun 14, with a total market value of approximately $922.34K. Source: A
RxSight, Inc. To Participate in the Truist Securities Medtech Conference
Oculis Publishes Results of 2024 Annual General Meeting and Announces Appointments to Its Board of Directors and Scientific Advisory Board
Shareholders approved all agenda items and proposals of the Board of DirectorsRobert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of DirectorsBaruch D. Kuppermann, M.D.,
Investors Interested In RxSight, Inc.'s (NASDAQ:RXST) Revenues
RxSight, Inc.'s (NASDAQ:RXST) price-to-sales (or "P/S") ratio of 23.5x may look like a poor investment opportunity when you consider close to half the companies in the Medical Equipment industry in th
What Makes RxSight, Inc. (RXST) a Strong Momentum Stock: Buy Now?
RxSight(RXST.US) Director Buys US$305.46K in Common Stock
$RxSight(RXST.US)$ Director Tammenoms Bakker Juliet purchased 5,000 shares of common stock on May 17, 2024 at an average price of $61.0913 for a total value of $305.46K.Source: Announcement What is st